|
|
Article: Barr Receives Tentative Approval for Generic Niaspan(R) 500 mg and 750 mg Extended-Release Tablets.
- Article from:
- PR Newswire
- Article date:
- June 16, 2003
CopyrightCOPYRIGHT 2003 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Barr Laboratories, Inc. today announced that it has received tentative approval from the U.S. Food & Drug Administration (FDA) for its generic version of Kos Pharmaceutical, Inc.'s (Kos) Niaspan(R) 500 mg and 750 mg Extended-Release Tablets (Niacin Extended-Release Tablet). The Company is currently challenging the validity and/or infringement of certain patents held by Kos for Niaspan 500 mg and 750 mg Extended-Release Tablets and a trial in the Federal District Court in New York is currently scheduled for December 2004.
The Company announced on May 12, 2003 that it had received tentative approval for its generic version of Kos Pharmaceutical, Inc.'s (Kos) ...